You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
珍寶島(603567.SH)上半年扣非歸母淨利增15.74%至2億元
格隆匯 08-23 17:07

格隆匯8月23日丨珍寶島(603567.SH)公佈2019上半年業績,公司實現營業收入14.69億元,同比增長16.34%;實現歸屬於上市公司股東的淨利潤2.37億元,同比下降4.55%。實現歸屬於上市公司股東扣除非經常性損益的淨利潤2億元,同比增長15.74%。

質量認證工作圓滿完成。哈珍寶車間GMP認證、雞西公司車間GMP認證、化藥新品種原輔料供應商庫的建設等三項工作已經按照計劃完成。其餘品種再註冊工作方案、新品種上市工作方案、珍寶及虎林公司口服品種研究工作、幹部動態評價機制方案、校企合作“訂單班”實施方案、人員輪崗工作方案等32項工作穩步推進。

公司正常推進在研化藥製劑項目32項中,一類化學創新藥項目3項,2項獲批臨牀,1項準備申報臨牀研究;仿製藥一致性評價項目2項,其中鹽酸克林黴素膠囊一致性評價已通過審核,待發批件,另一個項目已完成註冊申報;仿製藥項目27項,其中,1項在發補研究中,1項準備註冊申報,1項開展預BE試驗,其他均處於藥學研究中。

亳州中藥材商品交易中心項目運營取得新突破,形成“1箇中心、2大模式、3大平台、4大體系、5大業務”經營模式,實施供應鏈金融,重點打造平台+實體的智慧藥市,實現線下市場、電子交易、電子商務高度融合,多力齊發和協同作戰,構建“互聯網+”環境下中藥材現代市場流通體系,引領傳統中藥產業轉型升級。截至2019年6月30日,交易中心綜合辦公樓(交易大廳)累計投入佔預算比例為79%,工程建設已完成98%,將於2019年9月9日正式開業;神農谷中藥電商物流基地累計投入佔預算比例為50.67%,其中9-1#已完工95%、9-2#已完工70%、9-3#已完工35%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account